Orphanet: A Randomized, Double Blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
x

Search for a networks

* (*) mandatory field

A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Nave Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : -
  • Sponsor : ABBVIE DEUTSCHLAND GMBH & CO. KG
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • AbbVie Deutschland GmbH & Co. KG
  • Mainzer Strae 81
  • 65189 WIESBADEN
  • GERMANY
  • More information
  • Phone  : 49 (0) 611 1720 0
  • Fax  : 49 (0) 611 1720 1244
  • Website
  • Contact secretary  :
Last update: November 2019

Participants

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.